Spike Protein Ace2

Anti-ACE2 human mAb (IgG)
E24AHA007 Human,-Human-IgG1.-Affinity:-40.89-nM(ELISA).
EUR 416.5
Description: Human, Human IgG1. Affinity: 40.89 nM（ELISA）.

Human IgG antibody Laboratories manufactures the spike protein ace2 reagents distributed by Genprice. The Spike Protein Ace2 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Spike products are available in stock. Specificity: Spike Category: Protein Group: Ace2

True Blue
5(mg
EUR 635

True Blue
5x5(mg
EUR 2705

True Blue
10mg Ask for price
Description: True Blue

True Blue
1g Ask for price
Description: True Blue

True Blue
1mg Ask for price
Description: True Blue

True Blue
50mg Ask for price
Description: True Blue

True Blue
5mg Ask for price
Description: True Blue

Recombinant Human ACE2 His and DYKDDDDK Tag
0.05mg
EUR 410

Recombinant Human ACE2 His and DYKDDDDK Tag
0.1mg
EUR 590

Recombinant Human ACE2 His and DYKDDDDK Tag
0.5mg
EUR 1975

Recombinant Human ACE2 His and DYKDDDDK Tag
5x0.5mg
EUR 8880

Recombinant Human ACE2 Protein with His and Avi tag
0.1mg
EUR 520

Ace2 information

PEDV Spike Protein
MBS564233-01mg 0.1mg
EUR 610

PEDV Spike Protein
MBS564233-5x01mg 5x0.1mg
EUR 2600

Spike S1 (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit
79954 96 rxns.
EUR 845
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection_x000D_The SARS-CoV-2 Spike S1:ACE2 Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike S1 protein is attached to a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike S1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader.

Spike RBD (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit
78018 96 rxns.
EUR 600
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Receptor Binding Domain (RBD) of Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_
The Spike RBD (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike RBD protein is attached to a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike RBD on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader.

ACE2:Spike RBD (SARS-CoV-2) Inhibitor Screening Colorimetric Assay Kit
78031 96 rxns.
EUR 630
Description: Coronavirus disease 2019 (COVID-19) increases the risk of developing Acute Respiratory Distress Syndrome (ARDS), which is often fatal at the late stages of the infection when the SAR-CoV-2 virus causes significant damage to the lungs. As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein receptor binding domain (RBD) recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection.The ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of Fc-tagged Spike protein by HRP-labeled Anti-mouse-Fc. Only a few simple steps on a microtiter plate are required for the assay. First, ACE2 protein is attached to a clear nickel-coated 96-well plate. Next, SARS-CoV-2 Spike-Fc is incubated with ACE2 on the plate. Finally, the plate is treated with HRP-labeled anti-Fc, followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader.

Spike S1-Biotin (16-685) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78281 384 rxns.
EUR 1070
Description: The Spike S1-Biotin (16-685) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1 (B.1.617.2.1; Delta Plus Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78295 384 rxns.
EUR 930
Description: The Spike S1 (B.1.617.2.1; Delta Plus Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (B.1.617.2.1; Delta Plus Variant) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1 (K417T, E484K, N501Y) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78293 384 rxns.
EUR 930
Description: The Spike S1 (K417T, E484K, N501Y) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (K417T, E484K, N501Y) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1 (B.1.1.529 BA.1, Omicron Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78358 384 rxns.
EUR 1070
Description: The Spike S1 (B.1.1.529 BA.1, Omicron Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (B.1.1.529 BA.1, Omicron Variant) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1 Protein-Fc
E24PNA001 2019-nCoV-Recombinant-Protein-Antigen,SARS-CoV-2-Spike-S1-Protein(Fc-Tag)
EUR 416.5
Description: 2019-nCoV Recombinant Protein Antigen,SARS-CoV-2 Spike S1 Protein (Fc Tag)

Spike S1 Protein-Fc
MBS8574738-01mg 0.1mg
EUR 705

Spike S1 Protein-Fc
MBS8574738-5x01mg 5x0.1mg
EUR 2910

MERS Spike Protein RBD
MBS515779-001mg 0.01mg
EUR 225

MERS Spike Protein RBD
MBS515779-002mg 0.02mg
EUR 290

MERS Spike Protein RBD
MBS515779-005mg 0.05mg
EUR 365

MERS Spike Protein RBD
MBS515779-01mg 0.1mg
EUR 495

MERS Spike Protein RBD
MBS515779-5x01mg 5x0.1mg
EUR 1965

Spike S1 Protein-His
MBS8574739-01mg 0.1mg
EUR 705

Spike S1 Protein-His
MBS8574739-5x01mg 5x0.1mg
EUR 2910

Spike S1 (B.1.1.7; Alpha Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78282 384 rxns.
EUR 930
Description: The Spike S1 (B.1.1.7; Alpha Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (B.1.1.7; Alpha Variant) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1 (P.1; Gamma Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78284 384 rxns.
EUR 1070
Description: The Spike S1 (P.1; Gamma Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between Spike S1 (P.1) (SARS-CoV-2) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

SARS-CoV Spike Protein
abx060656-100g 100 µg Ask for price

SARS-CoV Spike Protein
abx060656-10g 10 µg
EUR 1962.5

SARS-CoV Spike Protein
abx060656-50g 50 µg Ask for price

SARS-CoV Spike Protein
abx060657-100g 100 µg Ask for price

SARS-CoV Spike Protein
abx060657-10g 10 µg
EUR 1962.5

SARS-CoV Spike Protein
abx060657-50g 50 µg Ask for price

SARS-CoV Spike Protein
abx060655-100g 100 µg Ask for price